The Fly

Qiagen weighing sale of stake in $1B bioinformatics unit, Bloomberg says

Qiagen is working with advisers as it considers selling a minority stake in its bioinformatics unit in a deal that could value the business at more than $1B, sources tell Bloomberg’s Dinesh Nair, Michelle Davis and Tim Loh.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on QGEN:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More